AI and Safety: Finding the Signals that Matter
How will AI best be positioned to help safety professionals best utilize their time and resources?
In this interview from DIA 2023, Greg Ball, Safety Data Scientist and Founder of ASAP Process Consulting, discusses artificial intelligence and its role to help safety scientists quickly sort through the hay, to find the needles in data signals.
Ball draws on his externsive experience as a biostatistician who has worked in various pharma companies to provide use case scenarios.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Phase III KEYNOTE-564 Trial Data Show Keytruda Improves Survival in Renal Cell Carcinoma
January 29th 2024Trial shows Keytruda improved overall survival by 38% compared with placebo in in patients with renal cell carcinoma at intermediate-high or high risk of recurrence after nephrectomy or nephrectomy and resection of metastatic lesions.
